Skip to main content
. 2017 Mar 14;88(11):1062–1068. doi: 10.1212/WNL.0000000000003696

Table 1.

Risk of developing Alzheimer disease (AD) among hormone therapy (HT) users (according to type of therapy used) in the whole cohort (n = 8,195)

graphic file with name NEUROLOGY2016743146TT1.jpg